Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation.

Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F.

Calcif Tissue Int. 1997 Feb;60(2):155-9.

PMID:
9056163
2.

Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.

Valero MA, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F.

Calcif Tissue Int. 1995 Jul;57(1):15-9.

PMID:
7671159
3.

Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.

Shane E, Rodino MA, McMahon DJ, Addesso V, Staron RB, Seibel MJ, Mancini D, Michler RE, Lo SH.

J Heart Lung Transplant. 1998 Nov;17(11):1089-96.

PMID:
9855448
4.

Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.

Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ.

Osteoporos Int. 1993 Dec;3(6):322-9.

PMID:
8292843
5.

Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.

Wang SX, Li H.

Chin Med J (Engl). 2008 Jul 20;121(14):1280-4.

PMID:
18713548
6.
7.

Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.

Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, Schmid C.

Calcif Tissue Int. 2000 Aug;67(2):116-21.

PMID:
10920215
8.

Magnesium deficiency and bone loss after cardiac transplantation.

Boncimino K, McMahon DJ, Addesso V, Bilezikian JP, Shane E.

J Bone Miner Res. 1999 Feb;14(2):295-303.

9.

High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.

Glendenning P, Kent GN, Adler BD, Matz L, Watson I, O'Driscoll GJ, Hurley DM.

Clin Endocrinol (Oxf). 1999 Mar;50(3):347-55.

PMID:
10435061
10.
11.

Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.

Zamberlan N, Castello R, Gatti D, Rossini M, Braga V, Fracassi E, Adami S.

Osteoporos Int. 1997;7(2):133-7.

PMID:
9166393
12.

Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.

Gilfraguas L, Guadalix S, Martinez G, Jodar E, Vara J, Gomez-Sanchez MA, Delgado J, De La Cruz J, Lora D, Hawkins F.

Prog Transplant. 2012 Sep;22(3):237-43.

PMID:
22951500
13.

Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation.

Henderson K, Eisman J, Keogh A, MacDonald P, Glanville A, Spratt P, Sambrook P.

J Bone Miner Res. 2001 Mar;16(3):565-71.

14.

Mechanisms of bone loss after cardiac transplantation.

Guo CY, Johnson A, Locke TJ, Eastell R.

Bone. 1998 Mar;22(3):267-71.

PMID:
9514219
15.
16.

The use of cyclical etidronate in osteoporosis: changes after completion of 3 years treatment.

Fairney A, Kyd P, Thomas E, Wilson J.

Br J Rheumatol. 1998 Jan;37(1):51-6.

17.

Treatment of osteopenia and osteoporosis after kidney transplantation.

Grotz WH, Rump LC, Niessen A, Schmidt-Gayk H, Reichelt A, Kirste G, Olschewski M, Schollmeyer PJ.

Transplantation. 1998 Oct 27;66(8):1004-8.

PMID:
9808483
18.

Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.

Abe Y, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K.

Clin Endocrinol (Oxf). 2000 Feb;52(2):203-9.

PMID:
10671948
20.

Lumbar spine bone mineral density in diabetic children with recent onset.

De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O.

Horm Res. 1998;50(4):193-6.

PMID:
9838239
Items per page

Supplemental Content

Write to the Help Desk